Alternative names (4)
interventionModel • interventionType • keyInterventions • mainInterventionRandom triples
| Subject | Object |
|---|---|
| gptkb:ProMISe_trial | early goal-directed therapy |
| gptkb:NCT02475681 | gptkb:Placebo |
| gptkb:NCT03830207 | Parallel Assignment |
| gptkb:Ending_Preventable_Child_and_Maternal_Deaths | skilled birth attendance |
| gptkb:NCT02142738 | gptkb:Nivolumab |
| gptkb:NCT05149502 | gptkb:TNG348 |
| gptkb:NCT05020678 | gptkb:Molnupiravir |
| gptkb:Relating_Clinical_Outcomes_in_Multiple_Myeloma_to_Personal_Assessment_of_Genetic_Profile_Study | genetic profiling |
| gptkb:FELIX_study | gptkb:UCART123 |
| gptkb:Diabetes_Prevention_Program_(DPP)_clinical_trial | lifestyle modification |
| gptkb:Sweet_Heart_Failure_with_Preserved_Ejection_Fraction:_Randomized_Trial | gptkb:empagliflozin |
| gptkb:S8814_(breast_cancer_trial) | chemotherapy |
| gptkb:Crisis_Teams | short-term |
| gptkb:Malaria_Consortium_SMC | preventive treatment |
| gptkb:KEYNOTE-024 | gptkb:pembrolizumab |
| gptkb:ReActiv8-B_Study | implantable neurostimulation device |
| gptkb:NCT03768413 | Teriflunomide |
| gptkb:NCT03830207 | gptkb:Ritonavir |
| gptkb:CLEOPATRA_trial | gptkb:trastuzumab |
| gptkb:CLEOPATRA_trial | docetaxel |